Persistent airway inflammation, mucus production, and airway hyperreactivity are the major contributors to the frequency and severity of asthma. Why lung inflammation persists in asthmatics remains unclear. It has been proposed that Fas-mediated apoptosis of inflammatory cells is a fundamental mechanism involved in the resolution of eosinophilic airway inflammation. Because infiltrating eosinophils are highly sensitive to Fas-mediated apoptosis, it has been presumed that direct ligation of Fas on eosinophils is involved. Here, we utilize adoptive transfers of T cells to demonstrate that the delayed resolution of eosinophilia in Fas-deficient mice is a downstream effect of Fas deficiency on T cells, not eosinophils. Interestingly, the mice that received Fas-deficient T cells, but not the controls, developed a persistent phase of inflammation that failed to resolve even 6 wk after the last challenge. This persistent phase correlated with decreased interferon (IFN)γ production by Fas-deficient T cells and could be reproduced with adoptive transfer of IFNγ-deficient T cells. These data demonstrate that Fas deficiency on T cells is sufficient for the development of long-term allergic airway disease in mice and implies that deregulation of death receptors such as Fas on human T cells could be an important factor in the development and/or chronic nature of asthma.
Skip Nav Destination
Article navigation
15 May 2006
Article|
April 17 2006
Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma
Jiankun Tong,
Jiankun Tong
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Search for other works by this author on:
Hozefa S. Bandulwala,
Hozefa S. Bandulwala
3Committee on Immunology,
Search for other works by this author on:
Robert A. Anders,
Robert A. Anders
2Department of Pathology
Search for other works by this author on:
Rebecca A. Shilling,
Rebecca A. Shilling
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Search for other works by this author on:
Diwakar D. Balachandran,
Diwakar D. Balachandran
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Search for other works by this author on:
Bohao Chen,
Bohao Chen
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Search for other works by this author on:
Joel V. Weinstock,
Joel V. Weinstock
5Division of Gastroenterology/Hepatology, Department of Medicine, Tufts University and New England Medical Center, Boston, MA 02111
Search for other works by this author on:
Julian Solway,
Julian Solway
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
Search for other works by this author on:
Kimm J. Hamann,
Kimm J. Hamann
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
3Committee on Immunology,
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
Search for other works by this author on:
Anne I. Sperling
Anne I. Sperling
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
3Committee on Immunology,
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
Search for other works by this author on:
Jiankun Tong
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Hozefa S. Bandulwala
3Committee on Immunology,
Bryan S. Clay
3Committee on Immunology,
Robert A. Anders
2Department of Pathology
Rebecca A. Shilling
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Diwakar D. Balachandran
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Bohao Chen
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
Joel V. Weinstock
5Division of Gastroenterology/Hepatology, Department of Medicine, Tufts University and New England Medical Center, Boston, MA 02111
Julian Solway
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
Kimm J. Hamann
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
3Committee on Immunology,
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
Anne I. Sperling
1Section of Pulmonary and Critical Care Medicine, Department of Medicine
3Committee on Immunology,
4Committee on Molecular Medicine, University of Chicago, Chicago, IL 60637
CORRESPONDENCE Anne I. Sperling: [email protected]
Abbreviations used: AHR, airway hyperreactivity; B6, C57BL/6; BAL, bronchoalveolar lavage; DN, double negative; DP, double positive; FasL, Fas ligand; Rrs, respiratory system resistance; SEA, soluble egg antigen.
Received:
August 19 2005
Accepted:
March 22 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (5): 1173–1184.
Article history
Received:
August 19 2005
Accepted:
March 22 2006
Citation
Jiankun Tong, Hozefa S. Bandulwala, Bryan S. Clay, Robert A. Anders, Rebecca A. Shilling, Diwakar D. Balachandran, Bohao Chen, Joel V. Weinstock, Julian Solway, Kimm J. Hamann, Anne I. Sperling; Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma . J Exp Med 15 May 2006; 203 (5): 1173–1184. doi: https://doi.org/10.1084/jem.20051680
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement